Used primarily as an intermediate in the synthesis of fluoroquinolone antibiotics. Its structure supports the development of antimicrobial agents effective against a broad spectrum of bacteria, including both Gram-positive and Gram-negative strains. The compound's fluorinated quinolone core enhances drug penetration and binding to bacterial enzymes, making it valuable in producing drugs that inhibit DNA gyrase and topoisomerase IV. Commonly found in the manufacturing chain of pharmaceuticals targeting urinary tract infections, respiratory infections, and certain gastrointestinal infections. Its derivatives are studied for improved potency, reduced resistance, and better pharmacokinetic profiles.